12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Brilinta regulatory update

AstraZeneca reached an agreement with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband) on the price for cardiovascular drug Brilique ticagrelor. These are the first completed negotiations under new drug pricing law AMNOG, which came into effect in January 2011.

The price, which will apply retroactively from...

Read the full 212 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >